From: Cell membrane-camouflaged inorganic nanoparticles for cancer therapy
Category | Core INP Material | Cancer Membrane Source | Cargo Loaded | Purpose | Ref |
---|---|---|---|---|---|
Metal nanomaterials | Gold nanocages | 4T1 | Doxorubicin | PTT; Hyperthermia-triggered drug release | [64] |
Rare-earth-doped nanomaterials | Ln-doped upconversion Nanocrystal | MDA-MB-435;CAL27; HCT116;DU145 | Null | FL imaging | [69] |
Sulfide nanomaterials | Hollow copper sulfide | B16-F10a | Doxorubicin | Drug delivery | [70] |
Oxide nanomaterials | Mesoporous silica | 4T1 | Glucose oxidase | Immunotherapy; Starvation therapy | [71] |
Mesoporous silica | LNCaP-AI | Doxorubicin; Calcium carbonate | Drug delivery; Ph-sensitive release | [72] | |
Mesoporous silica | MCF-7 | Doxorubicin; Parp inhibitor mefuparib hydrochloride | Drug delivery | [73] | |
Hollow manganese Dioxide | B16-F10 | Chlorin e6; Glucose oxidase | PDT; Starvation therapy | [74] | |
Iron oxide | UM-SCC-7;HeLa; HepG2; COS7 | Doxorubicin | Drug delivery | [63] | |
Superparamagnetic iron oxide | SMMC-7721 | Chlorin e6 | PDT; MRI imaging | [75] |